Search results
Billionaires Are Buying Beaten-Down Pfizer Stock Hand Over Fist. Should You Follow Their Lead?
Motley Fool via Yahoo Finance· 7 days agoPfizer stock lost nearly half its value over the past couple of years, but some of the world's most...
Pfizer's Path To Profit: A Look At PFE Stock As Drugmaker Rolls Out $1.5B In Cost Reductions - ...
Benzinga· 4 days agoPfizer Inc. PFE has recently launched a multi-year cost reduction initiative aimed at saving...
How Much Will Pfizer Pay Out in Dividends This Year?
Motley Fool via Yahoo Finance· 2 days agoAdding some shares to a diversified portfolio now looks like a smart move. Should you invest $1,000 in Pfizer right now? Before you buy stock in
Equities Analysts Issue Forecasts for Pfizer Inc.’s Q3 2025 Earnings (NYSE:PFE)
ETF DAILY NEWS· 3 days agoPfizer Inc. (NYSE:PFE – Free Report) – Stock analysts at Zacks Research dropped their Q3 2025 EPS estimates for Pfizer in a research ...
3 Stocks That Can Help You to Get Richer in 2025 and Beyond
Motley Fool via Yahoo Finance· 3 days agoNot only has it recently been trading at attractive levels, it's also currently sporting a fat...
Pfizer (NYSE:PFE) Shares Up 2%
ETF DAILY NEWS· 4 days agoPfizer Inc. (NYSE:PFE – Get Free Report)’s share price was up 2% during trading on Wednesday . The stock traded as high as $29.18 and ...
Pfizer (PFE) Starts Another Cost-Cut Plan to Save $1.5B by 2027
Zacks via Yahoo Finance· 4 days agoThis is the second cost-reduction program undertaken by Pfizer (PFE) in the past year. The first...
Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027 - Pfizer (NYSE:PFE)
Benzinga· 4 days agoPfizer Inc. PFE has launched a multi-year cost-cutting initiative aimed at saving approximately $1.5...
3 Healthcare Stocks to Buy Now: May 2024
InvestorPlace via Yahoo Finance· 6 days agoIt’s a great time to be looking at healthcare stocks to buy now. According to research from BlackRock, U.S. healthcare stocks have outperformed the...
This overlooked obesity-drug stock has 80% upside, JPMorgan says
Business Insider via Yahoo Finance· 6 days agoThe bank initiated coverage of the near-$2 billion biotech company with an "Overweight" rating and...
